A carregar...
Fondaparinux and acute coronary syndromes: update on the OASIS 5–6 studies
Anticoagulant therapy is a major component in the management of acute coronary syndromes (ACS). Four anticoagulant agents are currently commercially available for ACS, namely unfractionated heparin (UFH), enoxaparin, bivalirudin and fondaparinux. We describe the advantages of fondaparinux and the re...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2856573/ https://ncbi.nlm.nih.gov/pubmed/20407625 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|